Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assesment of JL1 Expression in B-cell Acute Lymphoblastic Leukemia

NCT04554381 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04554381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04554381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assesment of JL1 Expression in B-cell Acute Lymphoblastic Leukemia
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Unknown status
Start date
October 13, 2020
Completion date
November 30, 2023
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia